The Impact of MRI-Based Advanced Neuroimaging on Neurooncologists' Clinical Decision-Making in Patients With Posttreatment High-Grade Glioma: A Prospective Survey-Based Study
American Journal of Roentgenology · 2024
DOI: 10.2214/ajr.24.31595 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Roentgenology, 2024. Verfasst von Samir A Dagher und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX 77030. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Magnetic Resonance Imaging, Neuroimaging. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND. Advanced MRI-based neuroimaging techniques, such as perfusion and spectroscopy, have been increasingly incorporated into routine follow-up protocols in patients treated for high-grade glioma (HGG), to help differentiate tumor progression from treatment effect. However, these techniques' influence on clinical management remains poorly understood. OBJECTIVE. The purpose of this article was to evaluate the impact of MRI-based advanced neuroimaging on clinical decision-making in patients with HGG after treatment. METHODS. This prospective study, performed at a comprehensive cancer center from March 1, 2017, to October 31, 2020, included adult patients treated by chemoradiation for WHO grade 4 diffuse glioma who underwent MRI-based advanced neuroimaging (comprising multiple perfusion imaging sequences and spectroscopy) to further evaluate findings on conventional MRI equivocal for tumor progression versus treatment effect. The ordering neurooncologists completed surveys before and after each advanced neuroimaging session. The percent of episodes of care with a change between the intended and actual management plan on the surveys conducted before and after advanced neuroimaging, respectively, was computed and compared with a published percent using the Wald test for independent samples proportions. RESULTS. The study included 63 patients (mean age, 54.6 ± 12.9 [SD] years; 36 women, 27 men) who underwent 70 advanced neuroimaging sessions. Ordering neurooncologists' intended and actual management plans on the surveys completed before and after advanced neuroimaging, respectively, differed in 44% (31/70; 95% CI: 33-56%) of episodes, which differed from the published frequency of 8.5% (5/59) (p < .001). These management plan changes included selection of a different plan for six of eight episodes with an intended plan to enroll patients in a clinical trial, 12 of 19 episodes with an intended plan to change chemotherapeutic agents, four of eight episodes with an intended plan of surgical intervention, and one of two episodes with an intended plan of reirradiation. The ordering neurooncologists found advanced neuroimaging to be helpful in 93% (65/70; 95% CI: 87-99%) of episodes. CONCLUSION. Neurooncologists' management plans changed in a substantial fraction of adult patients with HGG who underwent advanced neuroimaging to further evaluate conventional MRI findings equivocal for tumor progression versus treatment effect. CLINICAL IMPACT. The findings support incorporation of advanced neuroimaging into HGG posttreatment monitoring protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Houston, TX 77030.
- Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Section of Neuroradiology, Yale New Haven Hospital, New Haven, CT.
- Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Neurological Sciences, Section of Neuro-Oncology, Rush University Medical Center, Chicago, IL.
Zitieren
APA
Dagher, S. A., Liu, H. L., Ozkara, B. B., Calle, S., Kaya, D., Gule-Monroe, M. K., Chasen, N. N., Schellingerhout, D., Learned, K. O., Shah, K. B., Johnson, J. M., Sun, J., Schomer, D. F., Kumar, V. A., Wintermark, M., Majd, N. K., Nam, J. Y., & Chen, M. M. (2024). The Impact of MRI-Based Advanced Neuroimaging on Neurooncologists' Clinical Decision-Making in Patients With Posttreatment High-Grade Glioma: A Prospective Survey-Based Study. American Journal of Roentgenology. https://doi.org/10.2214/ajr.24.31595
Vancouver
Dagher SA, Liu HL, Ozkara BB, Calle S, Kaya D, Gule-Monroe MK, et al. The Impact of MRI-Based Advanced Neuroimaging on Neurooncologists' Clinical Decision-Making in Patients With Posttreatment High-Grade Glioma: A Prospective Survey-Based Study. American Journal of Roentgenology. 2024. doi:10.2214/ajr.24.31595
BibTeX
@article{Dagher2024,
author = {Dagher, Samir A and Liu, Ho-Ling and Ozkara, Burak Berksu and Calle, Susana and Kaya, Diana and Gule-Monroe, Maria K and Chasen, Noah N and Schellingerhout, Dawid and Learned, Kim O and Shah, Komal B and Johnson, Jason M and Sun, Jia and Schomer, Donald F and Kumar, Vinodh A and Wintermark, Max and Majd, Nazanin K and Nam, Joo Yeon and Chen, Melissa M},
title = {The Impact of MRI-Based Advanced Neuroimaging on Neurooncologists' Clinical Decision-Making in Patients With Posttreatment High-Grade Glioma: A Prospective Survey-Based Study},
journal = {American Journal of Roentgenology},
year = {2024},
doi = {10.2214/ajr.24.31595}
}
EUVIMED